Vir Biotechnology VIR
NASDAQ VIR
$11.17 -0.12 (-1.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Selling, General & Administrative (2018 - 2026)

Updated

Vir Biotechnology (VIR) recorded Selling, General & Administrative of $30.2 million in Q2 2026, up 35.5% from $22.28 million a year earlier and up 29.4% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Selling, General & Administrative (2018 - 2026) Analysis & Trends

On a TTM basis, Vir Biotechnology's Selling, General & Administrative came in at $99.38 million as of Jun 30, 2026, up 0.7% year-over-year; for FY2025, it was $92.07 million, down 22.6% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $119.03 million in FY2024 (-31.8%), $174.44 million in FY2023 (+7.8%), $161.76 million in FY2022 (+0.6%) and $160.79 million in FY2021 (+126.7%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q2 2024.
  • On a year-over-year basis, Selling, General & Administrative rose in 1 of the last eight quarters, with an average decline of 15.6%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 167.8% in Q3 2021, against a decline of 37.1% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $23.34 million (Q1 2026), $23.62 million (Q4 2025) and $22.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Vir Biotechnology 1.89 Bn 1.89 Bn 238.95 Mn 30.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.20 Mn
Mar 31, 2026 23.34 Mn
Dec 31, 2025 23.62 Mn
Sep 30, 2025 22.23 Mn
Jun 30, 2025 22.28 Mn
Mar 31, 2025 23.94 Mn
Dec 31, 2024 26.70 Mn
Sep 30, 2024 25.74 Mn
Jun 30, 2024 30.27 Mn
Mar 31, 2024 36.32 Mn
Dec 31, 2023 41.22 Mn
Sep 30, 2023 40.93 Mn
Jun 30, 2023 45.51 Mn
Mar 31, 2023 46.78 Mn
Dec 31, 2022 38.74 Mn
Sep 30, 2022 43.17 Mn
Jun 30, 2022 41.59 Mn
Mar 31, 2022 38.26 Mn
Dec 31, 2021 55.78 Mn
Sep 30, 2021 50.50 Mn
API Access

Vir Biotechnology Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VIR&period=max&api_key=YOUR_API_KEY